Welcome To NewsFlash Extra

Current NewsFlash Bulletins And Extras Latest stories in OTC.newsflash   12 March 2010,  HYPERMARCAS GOES HYPERACTIVE   12 March 2010,  INCIDENCE OF MINOR AILMENTS VARIES BY REGION   12 March 2010,  APSMI ON THE WAY   12 March 2010,  SWITCH HIGH ON AGENDA IN JAPAN   12 March 2010,  TAISHO ENDS SPECIAL RELATIONSHIP WITH SHAREHOLDING DRUGSTORES   12 March 2010,  AEON TO INCREASE STAKE IN CFS   12 March 2010,  VEMEDIA LOOKING FOR ACQUISITION OPPORTUNITIES   12 March 2010,  SANOFI-AVENTIS COMPLETES ACQUISITION OF CHATTEM   12 March 2010,  INSTITUT ROSELL-LALLEMAND BOOSTS PROBIOTIC PORTFOLIO   12 March 2010,  CINFA ACQUIRES GLYCILAX FROM ROVI   12 March 2010,  ZEGERID OTC EXPECTED IN STORES BY APRIL   12 March 2010,  HOMEOPATHIC TREATMENT FOR BACTERIAL VAGINOSIS LAUNCHED IN US   12 March 2010,  CAN PROBIOTIC GUM MAKE IT BETTER   12 March 2010,  GADGET COULD OFFER ALTERNATIVE MIGRAINE RELIEF   12 March 2010,  … CRUCIAL FOR IMMUNE SYSTEM   12 March 2010,  VITAMIN D INSUFFICIENCY LINK TO MUSCLE FAT   12 March 2010,  ASMI STRESSES NSAIDs ARE SAFE   12 March 2010,  MORE PHYTOSTEROLS APPROVED   12 March 2010,  FDA STANDS FIRM ON ZICAM   12 March 2010,  BID TO EXTEND PHARMACY AVAILABILITY OF VOLTAROL EMULGEL   12 March 2010,  McCAIN WITHDRAWS SUPPORT FOR SUPPLEMENTS BILL   12 March 2010,  NEW WEBSITE INFORMS CONSUMERS ABOUT SUPPLEMENTS   12 March 2010,  FIGHT THOSE WRINKLES WITH CURRY Current NewsFlash Extras Company Profiles   05 March 2010,  Bayer profile REVISED, RUSSIA, CHINA AND FOOD SUPPLEMENTS BOOST BAYER CONSUMER CARE   09 January 2009,  BMS Profile   12 February 2010,  Boehringer Ingelheim profile   22 January 2010,  Cadbury Profile   05 February 2010,  Daiichi-Sankyo   05 March 2010,  GSK profile - REVISED, GSK ASKED TO DROP BACTERIAL REMOVAL CLAIMS   15 January 2010,  Hayao   29 January 2010,  J&J profile   12 March 2010,  Merck (formerly S-P) REVISED - ZEGERID OTC EXPECTED IN STORES BY APRIL   12 March 2010,  Merck KGaA profile - REVISED, MERCK KGaA DOESN’T RULE OUT FURTHER M&A   29 January 2010,  NBTY profile   12 March 2010,  Novartis profile - REVISED BID TO EXTEND PHARMACY AVAILABILITY OF VOLTAROL EMULGEL   05 March 2010,  Nycomed profile - REVISED, NYCOMED REPORTS RESILIENT PANTOPRAZOLE SALES   05 February 2010,  Otsuka profile   05 March 2010,  P&G profile - REVISED, P&G CONSIDERING M&A ACROSS ALL PRODUCT LINES   05 March 2010,  Reckitt Benckiser profile - REVISED, RECKITT BENCKISER IN TROUBLE OVER GAVISCON SALES TO NHS   04 December 2009,  Rohto profile   19 February 2010,  Sanofi-Aventis profile, REVISED - SANOFI-AVENTIS COMPLETES ACQUISITION OF CHATTEM   12 February 2010,  Taisho Profile REVISED - TAISHO TO END SPECIAL AGREEMENT WITH SHAREHOLDING DRUGSTORES   05 February 2010,  Takeda Profile   12 March 2010,  Wyeth Pfizer profile - REVISED, INTENSIFYING BATTLE TO ACQUIRE RATIOPHARM? M&A Registers   04 January 2010,  M&A Register 1996-2009 NEW!   12 March 2010,  M&A Register 2010 Hot Topics   12 December 2008,  Advisory OTCs   29 October 2004,  Deregulation in Japan   27 October 2006,  German healthcare reforms   17 February 2006,  Guest Feature - Wellness in the OTC World (Suresh Kumar)   04 February 2005,  RFID News Briefings   14 May 2007,  Aché: The Aché Story   17 December 2004,  Acne remedies global leading brands   06 May 2005,  Australia OTC market 2000-04   07 December 2007,  BMS OTC Brands   02 February 2007,  BMS, Sanofi-Aventis M&A Review & Analysis   01 September 2006,  Brazil OTC market briefing   15 June 2007,  Brazil: Progress of Top Systemic Analgesic Brands   13 April 2007,  CEE Local Players   19 October 2007,  China's Top OTC Marketers   21 September 2007,  Consumer Healthcare Profit Margins   11 September 2009,  DB6 2009: Mid Year Briefing   03 September 2004,  Ephedra briefing   12 March 2004,  European generics and private label   27 May 2005,  Growth in Europe's major OTC markets   28 November 2008,  Indonesia: OTC Market   22 December 2006,  J&J's acquisition of Pfizer CH - Briefing & analysis   31 March 2006,  Japan briefing   23 September 2005,  Mexico OTC briefing   14 October 2005,  Mid-year trends 2005   01 June 2007,  NRT per capita spend 2006 in the Top 20 OTC Markets   23 February 2007,  Nycomed acquires Altana Pharma – the Facts and Figures   08 October 2004,  Per capita spends on OTC   31 August 2007,  PSE briefing   09 March 2007,  PSE: UK MHRA Consultation on reverse-switch   29 August 2008,  Russia's Top OTC Marketers   10 October 2008,  Rx-to-OTC Switch: The Key Factors to Consider   08 April 2005,  Taiwan OTC market briefing   23 April 2007,  The Nicholas Hall Awards 2007   03 April 2009,  Top 20 OTC Countries 2008   11 November 2005,  UK price wars   24 March 2005,  US OTC allergy remedies: Claritin's impact   09 May 2008,  Wal-Mart's US$4 OTC Range – Brand & Private Label Price Comparisons Nicholas Hall's Overviews   05 October 2007,  DB6 2007: Mid Year Briefing   06 February 2004,  Global trends H2 2003   05 October 2004,  Nicholas Hall at the Sino-US Drugstore Forum   16 April 2004,  Nicholas Hall previews DB6 2004   16 April 2004,  Nicholas Hall reviews CHPA meeting   13 April 2006,  OTC Growth Companies   04 March 2005,  OTC market trends & data 2004:   18 May 2007,  OTC Network Partners @ Nicholas Hall   17 February 2006,  Provisional Global OTC Figures for 2005